Literature DB >> 3430967

Complement activation in experimental IgA nephropathy: an antigen-mediated process.

A Rifai1, A Chen, H Imai.   

Abstract

Complement activation associated with immune complex glomerular deposition plays an important role in renal injury. In the present studies we performed three series of experiments to identify how IgA immune complexes activate complement. The first series of experiments was designed to determine whether the presence of an antigen within a glomerular IgA immune deposit is required for complement activation. In these experiments, large-sized covalently cross-linked IgA oligomers (X-IgA) were prepared with purified IgA anti-dinitrophenyl (DNP) and a bivalent affinity-labeling antigen, bis-2,4-DNP-pimelic acid ester. These X-IgA oligomers have free antigen-binding sites that will bind DNP-conjugated antigens. Two groups of mice were treated with either X-IgA or X-IgA followed, after two hours, by an antigen DNP-Ficoll. Immunofluorescent examination of renal tissues, obtained six hours after the initial injection, revealed an equal intensity of IgA glomerular deposits in both groups of mice. Glomerular C3 deposits were only detectable in the renal tissues of mice that had DNP-Ficoll bound to X-IgA. In the second series of experiments, a pair of preformed IgA immune complexes, differing only in one antigenic structural feature (DNP), were used to examine the role of the antigen in inducing glomerular C3 deposits in two groups of mice. These pre-formed immune complexes were prepared with IgA anti-phosphorylcholine (PC) and either PC-conjugated to bovine serum albumin (PC-BSA) or PC-BSA which was further modified with DNP (PC/DNP-BSA). Although the IgA immunofluorescent intensity and pattern in the glomerular deposits were equivalent for both groups, intense C3 deposits were exclusively associated with the PC/DNP-BSA-containing immune complexes. Analysis of the relative conversion of normal human serum C3 to inactive C3b (iC3b) by X-IgA, various antigens and their respective IgA immune complexes was highly dependent on the nature of the antigen.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3430967     DOI: 10.1038/ki.1987.284

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

Review 1.  The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura.

Authors:  J F Knight
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

Review 2.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

3.  IgA immune aggregates stimulate platelet-activating factor and superoxide anion production by human neutrophils. A comparison with IgG aggregates.

Authors:  P Hernando; J Egido; R de Nicolas; E Gonzalez
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  Lack of complement activation by human IgA immune complexes.

Authors:  H Imai; A Chen; R J Wyatt; A Rifai
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

Review 5.  Immunopathogenesis of experimental IgA nephropathy.

Authors:  A Rifai
Journal:  Springer Semin Immunopathol       Date:  1994

6.  Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura.

Authors:  D J O'Donoghue; A Darvill; F W Ballardie
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

7.  An acute model for IgA-mediated glomerular inflammation in rats induced by monoclonal polymeric rat IgA antibodies.

Authors:  R K Stad; J A Bruijn; D J van Gijlswijk-Janssen; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

8.  In vivo activation of complement by IgA in a rat model.

Authors:  R K Stad; W M Bogers; M E Thoomes-van der Sluys; L A Van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

9.  Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy.

Authors:  Kenji Satake; Yoshio Shimizu; Yohei Sasaki; Hiroyuki Yanagawa; Hitoshi Suzuki; Yusuke Suzuki; Satoshi Horikoshi; Shinichiro Honda; Kazuko Shibuya; Akira Shibuya; Yasuhiko Tomino
Journal:  BMC Nephrol       Date:  2014-06-13       Impact factor: 2.388

10.  Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration.

Authors:  Yue Hu; Ozan S Kumru; Jian Xiong; Lorena R Antunez; John Hickey; Yang Wang; Lisa Cavacini; Mark Klempner; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2019-07-29       Impact factor: 3.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.